Avian influenza A (H7N9) is a novel influenza A virus that has caused severe human illnesses in China since 2013. Neuraminidase inhibitor (NI) treatment, systemic steroid use, and intensive respiratory care have been used to manage severe avian influenza infection. The timing for initiation of steroid treatment remains uncertain, and the harmful effects of immune suppression and the potential for prolonging viral replication have been reported in the literature. Here, we reported a case of H7N9 influenza infection in a patient with acute respiratory distress syndrome who was supported with extracorporeal membrane oxygenation and given NIs and systemic steroid in accordance with the viral load and the blood CD4 lymphocyte count.